Contact
Write to Us
Contact Us
Follow Us on Twitter
January 22, 2014
For a global health company we evaluated the expected incremental cost-effectiveness of one of their products. The cost-effectiveness outcome was needed to support adjuvant therapy decision making versus current clinical practice in the Netherlands. We… developed a Markov model to project distant recurrences survival, quality-adjusted life expectancy and direct medical […]
January 22, 2014
For a large pharmaceutical company, Panaxea was asked to perform a time-and-motion study to compare two administration methods of medicine.
January 22, 2014
In this project we performed an impact-analysis on scientific, translational/clinical and socio-economic aspects of a public-private partnership (PPP)
January 22, 2014
Point of Care Testing (POCT) is generally perceived to be more expensive on a unit-cost base than testing performed in a centralized laboratory. Consequently, introducing a new treatment protocol in the hospital setting, involving an increase in the number of POCT analyses performed, requires a thorough analysis of accompanying costs […]
January 22, 2014
Decision analytic support model could be populated with hospital-specific data, and could thereby guide implementation decisions at local and hospital level
January 22, 2014
A large provider of haemodialysis services wanted to increase the market share of one of their products. They requested Panaxea 1) to develop a health economic value story to secure global reimbursement for this technology; 2) and to develop a model incorporating both a cost-effectiveness and budget impact analysis to […]